Tmunity Raises $100m Series A To Fund Next-Gen T-Cell Therapy Trials

Tmunity launched in early 2016 with $10m in seed funding for novel T-cell therapies, two of which are now in the clinic. The company reunites former Novartis cell therapy head Oz Azam and CAR-T researchers from the University of Pennsylvania.